🔴 Background information on the company's new directors and current directors 🔺 Archive for inspection

🔴 ### Detailed background of newly elected directors and their possible impact on the company

#### 1. Jason Kelly
Jason Kelly is the co-founder and CEO of Ginkgo Bioworks and has been a board member since the company was founded in 2008. He has a PhD in bioengineering and a bachelor's degree in chemical engineering and biology from the Massachusetts Institute of Technology (MIT). His leadership and scientific background have enabled him to play a key role in driving the company's growth and innovation [[❞]] (https://www.ginkgobioworks.com/about/) [[❞]] ( https://investors.ginkgobioworks.com/governance/board-of-directors/person-details/default.aspx?ItemId=f6001a87-ab56-4198-bbc3-d976218b09e3).

#### 2. Reshma Shetty
Reshma Shetty is also the co-founder of Ginkgo Bioworks and serves as the company's president and chief operating officer. She has over 15 years of experience in synthetic biology and has been named by Forbes magazine and Fast Company as one of the most innovative business figures. She has a bachelor's degree in computer science from the University of Utah and a doctorate in bioengineering from MIT [[❞]] (https://www.ginkgobioworks.com/about/) [[❞]] ( https://investors.ginkgobioworks.com/governance/board-of-directors/person-details/default.aspx?ItemId=f6001a87-ab56-4198-bbc3-d976218b09e3).

#### 3. Arie Belldegrun
Arie Belldegrun is the founder of Kite Pharma and has extensive experience in the biotech industry. His innovation and leadership in cancer immunotherapy has made him widely recognized in the biotechnology community. His addition will bring valuable industry knowledge and strategic insight to Ginkgo Bioworks and help the company expand in medicine and treatment [[❞]] (https://www.ginkgobioworks.com/about/).

#### 4. Ross Fubini
Ross Fubini is a founding partner of XYZ Ventures, which focuses on investing and supporting startups. His venture capital background and extensive web resources will help Ginkgo Bioworks secure additional capital and business opportunities [[❞]] (https://www.ginkgobioworks.com/about/).

#### 5. Kathy Hopinkah Hannan
Kathy Hopinkah Hannan is KPMG's former national managing partner with extensive finance and audit experience. Her expertise in corporate governance and risk management will strengthen Ginkgo Bioworks' corporate governance structure [[❞]] (https://www.ginkgobioworks.com/about/).

#### 6. Christian Henry
Christian Henry is the CEO of PacBio, focusing on genomics and bioinformatics. His leadership in high-throughput sequencing technology will help Ginkgo Bioworks improve its capabilities in genetic engineering and data analysis [[❞]] (https://www.ginkgobioworks.com/about/).

#### 7. Myrtle Potter
Myrtle Potter is the CEO of Sumitovant Biopharma and has extensive management experience in the pharmaceutical industry. Her addition will strengthen Ginkgo Bioworks' strategic and operational capabilities in the biopharmaceutical sector [[❞]] (https://www.ginkgobioworks.com/about/).

#### 8. Shyam Sankar
Shyam Sankar is Chief Operating Officer at Palantir Technologies, focusing on data analytics and artificial intelligence. His technical background will help Ginkgo Bioworks achieve breakthroughs in data-driven decision-making and artificial intelligence applications [[❞]] (https://www.ginkgobioworks.com/about/).

#### 9. Harry E. Sloan
Harry E. Sloan is a well-known investor and entrepreneur with extensive experience in the media and entertainment industry. His strategic perspective and commercial acumen will help Ginkgo Bioworks succeed in brand promotion and market expansion [[❞]] (https://www.ginkgobioworks.com/about/).

### Current Other Directors

According to Ginkgo Bioworks's corporate website and other public materials, other current directors include other founding members and executives of the company. Their detailed backgrounds and expertise are as follows:

- **Barry Canton**: Co-founder, responsible for the overall foundry technology strategy, and has a PhD in bioengineering from MIT.
- **Austin Che**: Co-founder with a focus on strategic partnerships and investments, and has a PhD in electrical engineering and computer science from MIT.
- **Tom Knight**: Co-founder, known as one of the founders of synthetic biology, worked at MIT for many years [[❞]] (https://en.wikipedia.org/wiki/Ginkgo_Bioworks) [[❞]) ( https://investors.ginkgobioworks.com/governance/board-of-directors/person-details/default.aspx?ItemId=f6001a87-ab56-4198-bbc3-d976218b09e3).

The diverse backgrounds and expertise of these board members cover diverse fields such as bioengineering, computer science, investment, and corporate management, and will provide Ginkgo Bioworks with comprehensive strategic guidance and support to help the company maintain its leading position in the rapidly growing biotechnology industry.

⭕ ### Jason Kelly
**Educational Background and Professional Achievement**: Jason Kelly has a bachelor's degree in chemical engineering and biology and a doctorate in bioengineering from the Massachusetts Institute of Technology (MIT). He is the co-founder and CEO of Ginkgo Bioworks, a leader in synthetic biology that provides platform services for cellular programming [[❞]] (https://www.biotech.senate.gov/bio-jason-kelly/) [❞] (https://www.weforum.org/people/jason-kelly/).

**Industry Influence**: Kelly's influence in biotechnology is significant. He has spoken many times at important industry conferences and participated in high-level discussions with government and industry leaders, such as speaking at the White House Biotech and Biomantry Summit [[❞]] (https://www.ginkgobioworks.com/2022/09/15/new-executive-order-to-bolster-biotech-ginkgo-ceo-at-white-house-ginkgo-vp-to-lead-arpa-h/) . He has also served as a director for several companies, including CM Life Sciences II [[❞]] (https://www.synbiobeta.com/speakers/jason-kelly).

### Reshma Shetty
**Educational Background and Professional Achievements**: Reshma Shetty also graduated from MIT with a doctorate in bioengineering. She is the co-founder of Ginkgo Bioworks, which focuses on driving the company's technological development and innovation.

**Industry Influence**: Shetty has extensive influence in the field of synthetic biology. She is the author of several academic papers within the industry and has spoken at several industry conferences. Her work has helped drive the application of Ginkgo in different markets such as agriculture, biomedicine, etc. [[❞]] (https://www.technologyreview.com/2021/08/24/1032308/is-ginkgos-synthetic-biology-story-worth-15-billion/) [[❞]) ( https://en.wikipedia.org/wiki/Ginkgo_Bioworks).

### Arie Belldegrun
**Educational Background and Professional Achievement**: Arie Belldegrun has a medical doctorate degree from the Hebrew University of Jerusalem and completed her professional training in urology at Harvard University. He is the founder of Kite Pharma, a company that has made breakthroughs in cancer immunotherapy.

**Industry impact**: Belldegrun is highly respected for its innovation and leadership in the biopharmaceutical sector. He is also a director of several biotech companies, including UroGen Pharma and Two River Group [[❞]] (https://www.biotech.senate.gov/bio-jason-kelly/) [[❞] (https://en.wikipedia.org/wiki/Ginkgo_Bioworks).

### Ross Fubini
**Educational Background and Professional Achievement**: Ross Fubini is a founding partner of XYZ Venture Capital, which focuses on investing in early-stage technology companies.

**Industry Influence**: Fubini has a deep background in venture capital and has played a significant role in the success of several tech companies and startups. His investment and strategic perspectives are important to Ginkgo's capital operations and market expansion [[❞]] (https://en.wikipedia.org/wiki/Ginkgo_Bioworks).

### Kathy Hopinkah Hannan
**Educational Background and Professional Achievement**: Kathy Hopinkah Hannan has degrees in accounting and business and is a certified public accountant. She has held key positions at Deloitte where she was responsible for corporate strategy and diversity initiatives.

**Industry impact**: Hannan has extensive experience in corporate governance, strategic planning, and corporate social responsibility. This background will help Ginkgo further improve its corporate compliance and social impact [[❞]] (https://en.wikipedia.org/wiki/Ginkgo_Bioworks).

### Christian Henry
**Educational Background and Professional Achievement**: Christian Henry has a bachelor's degree from the University of California San Diego and an MBA from the University of Santa Clara. He is the CEO of PacBio, focusing on genomics and bioinformatics technology.

**Industry impact**: Henry's leadership in genomics and bioinformatics has made him widely respected in the biotech community. His technical and market experience will bring Ginkgo an important resource in genomic engineering and data analysis [[❞]] (https://en.wikipedia.org/wiki/Ginkgo_Bioworks).

### Myrtle Potter
**Educational Background and Professional Achievement**: Myrtle Potter has a bachelor's degree from the University of Chicago. She has held executive positions at companies such as Genentech and Bristol-Myers Squibb.

**Industry impact**: Potter has extensive leadership experience in the pharmaceutical and biotech industries, and her business strategy and market insight will help Ginkgo expand in the biomedical sector [[❞]] (https://en.wikipedia.org/wiki/Ginkgo_Bioworks).

### Shyam Sankar
**Educational Background and Professional Achievement**: Shyam Sankar has a bachelor's degree in computer science from Cornell University and an MBA from Stanford University. He is Palantir Technologies' COO.

**Industry influence**: Sankar has a deep background in data analysis and technology management, and his technical experience will support Ginkgo's development in data-driven biotechnology solutions [[❞]] (https://en.wikipedia.org/wiki/Ginkgo_Bioworks).

### Harry E. Sloan
**Educational Background and Professional Achievement**: Harry E. Sloan has a law degree from the University of California, Los Angeles. He is the founder of Global Eagle Entertainment and has extensive experience in the entertainment and media industry.

**Industry impact**: Sloan's media and investment experience will help Ginkgo achieve greater success in brand strategy and marketing [[❞]] (https://en.wikipedia.org/wiki/Ginkgo_Bioworks).

Through the diverse backgrounds and rich experience of these directors, Ginkgo Bioworks was able to receive significant support in technological innovation, market expansion, corporate governance, etc., further strengthening its leading position in the field of synthetic biology.